Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
30 Cards in this Set
- Front
- Back
With a vaginal delivery, you wait to give pitocin until:
|
Placenta is delivered
|
|
With a c/s, you give pitocin as soon as:
|
The baby is out
|
|
In a c/s you give pitocin:
|
More rapidly (over 10 min)
|
|
Oxytocin can cause:
|
Hypotension
|
|
Oxytocin hypotension usually occurs after:
|
Rapid infusion
|
|
Oxytocin hypotension is usually:
|
Mild and transient (5 min duration)
|
|
Oxytocin side effects:
|
N/V, headache, water retention and reduced urine output
|
|
Oxytocin: water retention and reduced urine output occurs with:
|
Prolonged administration (ADH effect)
|
|
Oxytocin may be given in small IV boluses for rx of:
|
Uterine atony (2 mcg)
|
|
Complex of multiple biologically active amines:
|
Ergot alkaloids
|
|
Rx for migraines
|
Ergotamine
|
|
2nd line tx for uterine atony
|
Methylergonovine (Methergine)
|
|
Ergot derivatives are a :
|
Direct alpha adrenergic stimulator
|
|
Ergot derivatives cause:
|
Tense uterine cxs and generalized vasoconstriction
|
|
Ergot derivatives are not useful for:
|
Labor induction/augmentation
|
|
Ergot derivatives cause strong uterine stimulating properties which can cause:
|
Tetanic cxs and fetal compromise
|
|
Ergot derivatives are used as a second line drug for uterine atony not responding to:
|
Pitocin
|
|
Ergot derivatives are given:
|
IM or oral only
|
|
Ergot derivatives are:
|
Refrigerated
|
|
Ergot derivatives are metabolized by the
|
Liver
|
|
Ergot derivatives have a half life of:
|
2 hours
|
|
Ergot derivatives side effect:
|
Generalized arterial and venous vasoconstriction
|
|
Ergot derivatives side effect:
|
Small increases in bp
|
|
Ergot derivatives side effect:
|
Increase CVP and wedge pressure
|
|
Ergot derivatives side effect:
|
N/V
|
|
Ergot derivatives side effect if given IV:
|
Severe HTN, pulmonary edema, intracerebral hemorrhage, heart failure, seizures, cerebral edema, coronary artery vasoconstriction
|
|
Ergot derivatives should not be used in pts with:
|
Cardiac disease
|
|
Ergot derivatives should not be used in pts with:
|
HTN or PIH
|
|
Ergot derivatives should not be used in pts with:
|
PVD
|
|
Ergot derivatives potentiate sympathomimetics such as:
|
Ephedrine
|